Clarity or Corporate Secret? Battle Brews Over FDA Letters
By Dan McKay · May 5, 2026, 5:17 PM EDT
The U.S. Food and Drug Administration is facing increased pressure from drug developers to either roll back a new transparency policy they claim is exposing corporate secrets, or prepare to defend...
To view the full article, register now.